Imago BioSciences Inc logo

Imago BioSciences Inc

Imago BiosSciences is a clinical-stage therapeutics company developing treatments for malignant and life-threatening diseases for bone marrow.

6

Funding Rounds

$307.4m

Money raised

Overview

Imago BiosSciences is a clinical-stage therapeutics company developing treatments for malignant and life-threatening diseases for bone marrow.

Funding

Funding series

Funding Series Analysis

The company Imago BioSciences Inc has raised a total of $240.9m in funding over 6 rounds.

Key Insights:

  • Imago BioSciences Inc Initial public offering (IPO): $134.4m
  • Imago BioSciences Inc Series C round, November 19, 2020: $80m
  • Imago BioSciences Inc Series A round, October 31, 2014: $26.5m
  • Imago BioSciences Inc funding round, March 2019: $40m
  • Imago BioSciences, Inc. funding round, December 2014: $26.5m
Imago BioSciences Inc logo
Imago BioSciences Inc Initial public offering (IPO) $134.4m
Imago BioSciences Inc logo
Imago BioSciences Inc Series C round, November 19, 2020 $80m
Imago BioSciences Inc logo
Imago BioSciences Inc Series A round, October 31, 2014 $26.5m
Imago BioSciences Inc logo
Imago BioSciences Inc funding round, March 2019 $40m
Imago BioSciences Inc logo
Imago BioSciences, Inc. funding round, December 2014 $26.5m